Roy D. Baynes

Insider Reports History

Location
San Diego, CA
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roy D. Baynes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Natera, Inc. Director Common Stock 18.4K $4.13M $224.89 20 Nov 2025 Direct
Travere Therapeutics, Inc. Director Common Stock 37.5K $687K $18.33 15 May 2025 Direct
Atara Biotherapeutics, Inc. Director Common Stock 43.5K $16.9K $0.39 23 Jun 2022 Direct
Natera, Inc. Director Stock Option (right to buy) 0 $0 $25.03 20 Nov 2025 Direct
Atara Biotherapeutics, Inc. Director Non-Qualified Stock Option (Right to Buy) 31.5K 23 Jun 2022 Direct
Aardvark Therapeutics, Inc. Director Stock Option (right to buy) 30.5K 11 Jun 2025 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 25K 19 May 2025 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19.5K 15 May 2025 Direct

Insider Reports Filed by Roy D. Baynes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTRA Natera, Inc. 19 Nov 2025 14 -$2.28M 4 Director 21 Nov 2025, 20:05
NTRA Natera, Inc. 31 Oct 2025 1 $0 4 Director 04 Nov 2025, 21:05
NTRA Natera, Inc. 25 Jul 2025 1 $0 4 Director 29 Jul 2025, 21:05
NTRA Natera, Inc. 27 Jun 2025 1 $0 4 Director 01 Jul 2025, 21:15
AARD Aardvark Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:05
NRIX Nurix Therapeutics, Inc. 19 May 2025 1 $0 4 Director 19 May 2025, 17:32
TVTX Travere Therapeutics, Inc. 15 May 2025 2 $0 4 Director 16 May 2025, 19:00
NTRA Natera, Inc. 25 Apr 2025 1 $0 4 Director 29 Apr 2025, 20:35
NRIX Nurix Therapeutics, Inc. 11 Mar 2025 1 $0 4 Director 13 Mar 2025, 16:09
NRIX Nurix Therapeutics, Inc. 11 Mar 2025 0 $0 3 Director 13 Mar 2025, 16:07
AARD Aardvark Therapeutics, Inc. 12 Feb 2025 0 $0 3 Director 12 Feb 2025, 19:19
TVTX Travere Therapeutics, Inc. 06 Feb 2025 3 -$45.6K 4 Director 10 Feb 2025, 18:04
NTRA Natera, Inc. 31 Jan 2025 1 $0 4 Director 04 Feb 2025, 21:15
TVTX Travere Therapeutics, Inc. 23 Jan 2025 3 -$40K 4 Director 23 Jan 2025, 20:36
NTRA Natera, Inc. 15 Nov 2024 10 -$4.57M 4 Director 15 Nov 2024, 21:50
NTRA Natera, Inc. 25 Oct 2024 1 $0 4 Director 29 Oct 2024, 21:05
NTRA Natera, Inc. 26 Jul 2024 1 $0 4 Director 30 Jul 2024, 21:05
NTRA Natera, Inc. 28 Jun 2024 1 $0 4 Director 02 Jul 2024, 21:05
TVTX Travere Therapeutics, Inc. 08 May 2024 2 $0 4 Director 10 May 2024, 16:05
NTRA Natera, Inc. 26 Apr 2024 1 $0 4 Director 30 Apr 2024, 20:35
NTRA Natera, Inc. 26 Jan 2024 1 $13.7K 4 Director 30 Jan 2024, 20:05
NTRA Natera, Inc. 27 Oct 2023 1 $13.7K 4 Director 31 Oct 2023, 21:05
NTRA Natera, Inc. 28 Jul 2023 1 $12.8K 4 Director 01 Aug 2023, 21:05
NTRA Natera, Inc. 30 Jun 2023 2 $0 4 Director 05 Jul 2023, 21:05
NTRA Natera, Inc. 25 May 2023 2 $0 4 Director 26 May 2023, 21:05
TVTX Travere Therapeutics, Inc. 17 May 2023 2 $0 4 Director 19 May 2023, 16:06
NTRA Natera, Inc. 14 Apr 2023 1 $12.5K 4 Director 18 Apr 2023, 20:10
NTRA Natera, Inc. 13 Jan 2023 1 $12.5K 4 Director 18 Jan 2023, 20:35
NTRA Natera, Inc. 14 Oct 2022 1 $12.5K 4 Director 18 Oct 2022, 21:05
NTRA Natera, Inc. 08 Jul 2022 1 $0 4/A Director 02 Sep 2022, 20:05
ATRA Atara Biotherapeutics, Inc. 23 Jun 2022 2 $0 4 Director 27 Jun 2022, 16:48
NTRA Natera, Inc. 27 May 2022 2 $0 4 Director 01 Jun 2022, 21:05
NTRA Natera, Inc. 25 May 2022 2 $0 4 Director 27 May 2022, 21:45
TVTX Travere Therapeutics, Inc. 11 May 2022 2 $0 4 Director 12 May 2022, 20:18
ATRA Atara Biotherapeutics, Inc. 08 Jun 2021 2 $0 4 Director 09 Jun 2021, 19:03
NTRA Natera, Inc. 28 May 2021 4 $0 4 Director 02 Jun 2021, 19:58
TVTX Travere Therapeutics, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 21:25